FOSUN PHARMA (02196) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Shanghai Fosun Pharma Announces Drug Registration Acceptance
TipRanksNov 4 05:08 ET
Fosun Pharma (02196): The pharmaceutical registration applications for Levofloxacin Injection and Acyclovir Injection have been accepted by the National Medical Products Administration.
Fosun Pharma (02196) announced that Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (hereinafter referred to as the 'Company'...
Zhitong FinanceNov 4 04:59 ET
Express News | Shanghai Fosun Pharma - Drug Registration Applications of Levofloxacin Injection and Cytarabine Injection by Units Accepted by Nmpa
ReutersNov 4 04:58 ET
Fosun Pharma (600196.SH): A subsidiary holding company received acceptance of pharmaceutical registration application.
GraceUnion November 4th | Fosun Pharma (600196.SH) announced that its holding subsidiary Chongqing Yaoyou Pharmaceutical Co., Ltd.'s Levofloxacin Injection (referred to as "New Drug 1") and its holding subsidiary Gismei (Wuhan) Pharmaceutical Co., Ltd.'s Azacitidine Injection (referred to as "New Drug 2") have each had their pharmaceutical registration applications accepted by the National Medical Products Administration. Both New Drug 1 and New Drug 2 are chemical drugs independently developed by this group (i.e. the Company and its holding subsidiaries/units). New Drug 1 is intended for the following mild, moderate, and severe infections caused by sensitive bacteria: (1) Hospital-acquired pneumonia.
Gelonghui FinanceNov 4 03:35 ET
Hong Kong stock concept tracking | The end of medical insurance negotiations is very encouraging for innovative drugs to be included in medical insurance at reasonable prices (with concept stocks)
The on-site negotiation and bidding stages for the adjustment of the national medical insurance pharmaceutical catalog in 2024 officially ended recently.
Zhitong FinanceNov 3 20:45 ET
Earnings Update: Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHSE:600196) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Simply Wall StNov 1 18:44 ET

Comments

Spinee

Jun 24 21:45

HSI Opens Up 60 pts; LI AUTO & NIO Advance, as HENLIUS Rockets 21%

Hong Kong stocks opened higher in the morning. $Hang Seng Index (800000.HK)$opened 60 points or 0.3% higher at 18,088. $Hang Seng China Enterprises Index (800100.HK)$ opened 22 points or 0.3% higher at 6,463. $Hang Seng TECH Index (800700.HK)$ opened 11 points or 0.3% higher at 3,689.
$FOSUN PHARMA (02196.HK)$ proposed to privatise $HENLIUS (02696.HK)$ at $24.6 per share. HENLIUS opened rocketing 21.3% at $22.85, while FOSUN PHARMA opened lifting 1.2% at...

1

Spinee

Apr 25, 2023 11:34

HSI Slides 342 Pts; Techs & Pharmas Gloom

$Hang Seng Index (800000.HK)$ concluded the day at 19,617, down 342 pts or 1.7%. $Hang Seng China Enterprises Index (800100.HK)$ sagged 131 pts or 2% to 6,601. $Hang Seng TECH Index (800700.HK)$ faded 137 pts or 3.5% to 3,824. The turnover aggregated $106.657 billion.
Techs slid as the market continued to be watchful of the Sino-US relations:
$BABA-W (09988.HK)$ dived 3.2% to $84.1.
$TENCENT (00700.HK)$ sank 1.9% to $338.4.
$MEITUAN-W (03690.HK)$ , $XIAOMI-W (01810.HK)$ , ...

1

Senorita Earnings

Mar 1, 2023 23:54

Columns Expert Meeting Minutes | Seven Development Trends of the China Medical Aesthetics Industry

Core point
1. In the past three years, China's medical beauty industry has undergone earth-shaking changes, and non-surgical products occupy the mainstream
2. The brand is a marketing tool and a social contract for the legal entity to face society. Last year, it began to issue documents on supervising medical aesthetics, focusing on doctors' qualifications, marketing, and the capabilities of three types of ...

Spinee

Dec 14, 2022 00:12

The domestic COVID-19 oral drug Azifodine is planned to be sold online, and $FOSUN PHARMA (02196.HK)$ shares were opened 12% higher to 29 yuan.
$Pfizer (PFE.US)$ $AIM VACCINE (06660.HK)$

Spinee

Dec 6, 2022 21:36

In terms of allocation of Chinese stocks, it is suggested to focus on three main lines:

First, under the optimization of epidemic prevention, the repair market of damaged plates in the early stage, such as biomedical, aviation, wine travel and other plates;
Second, under the demand of stable growth, the industry policy margin is loose, such as the real estate industry chain and the Internet and other industries;
Third, under the theme of security for a long time, energy security, self contro...

7

2

02196 FOSUN PHARMA

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target